Table 1.
Demographic and clinical characteristics of PLWHA and controls.
| PLWH (n = 105) | Controls (n = 90) | p‐Value | |
|---|---|---|---|
| Age (years) | 38.7 ± 9.2 | 38.0 ± 9.2 | .585 |
| Male (n, %) | 92 (87.6%) | 71 (78.9%) | .101 |
| BMI (kg/m2) | 22.8 ± 3.3 | 23.2 ± 2.7 | .452 |
| Hypertension (n, %) | 12 (11.4%) | 11 (12.2%) | .864 |
| Diabetes (n, %) | 13 (12.4%) | 9 (11.1%) | .784 |
| Smoking history (n, %) | 33 (31.4%) | 34 (37.8%) | .352 |
| HIV exposure | |||
| Sexual (n, %) | 86 (81.9%) | ‐ | ‐ |
| Blood (n, %) | 11 (10.5%) | ‐ | ‐ |
| IVDU (n, %) | 8 (7.6%) | ‐ | ‐ |
| Duration of HIV infection (months) | 6 (4–8) | ||
| TC (mmol/L) | 4.21 (3.78–4.70) | 4.60 (4.15–5.00) | .003* |
| TG (mmol/L) | 1.43 (1.04–1.95) | 1.30 (1.00–1.50) | .016* |
| LDL‐C (mmol/L) | 2.51 ± 0.68 | 2.65 ± 0.58 | .130 |
| HDL‐C (mmol/L) | 1.13 ± 0.35 | 1.25 ± 0.31 | .013* |
| CD4+ Count (cells/μL) | 231 (130–387) | ‐ | ‐ |
| CD4+/CD8+ Ratio | 0.55 (0.34–0.78) | ‐ | ‐ |
| viral load (copies/mL) | 16,100 (494–50667) | ‐ | ‐ |
Note: *p < .05.
Abbreviations: BMI, body mass index; HDL‐C, high‐density lipoprotein cholesterol; HIV, human immunodeficiency virus; IVDU, intravenous drug users; LDL‐C, low‐density lipoprotein cholesterol; PLWHA, patients living with HIV/AIDS; TC, total cholesterol; TG, triglycerides.